To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks

NCT00946114 · clinicaltrials.gov ↗

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Hypertension

Interventions

DRUG: sildenafil
DRUG: sildenafil

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.